MKI67 and cholesteatoma: It is known that NF-κβ acts through a pathway with Ki-67 (the inhibitor of the DNA binding protein 1 (Id1) → NF-κB → cyclin D1 → Ki-67) and activates cell proliferation in human cholesteatoma [59].